title: Endometrial carcinoma with ectopic human chorionic gonadotropin expression.
abstract: •Aggressive course and treatment resistance characterize ectopic human chorionic gonadotropin.•Recurrence of endometrial cancer with ectopic hCG was treated with brachytherapy and EMACO.•The serum hCG level can serve as a marker in tumors with ectopic hCG expression.
authors.affiliation: Department of Obstetrics and Gynecology, Morehouse School of Medicine, Atlanta, GA, United States.
authors.forename: Regina
authors.initials: R
authors.lastname: Lee
authors.affiliation: Department of Obstetrics and Gynecology, Morehouse School of Medicine, Atlanta, GA, United States.
authors.forename: Roland
authors.initials: R
authors.lastname: Pattillo
authors.affiliation: AKESOgen, Inc, Norcross, GA, United States.
authors.forename: Mark
authors.initials: M
authors.lastname: Bouzyk
authors.affiliation: Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, United States.
authors.forename: Gabriela
authors.initials: G
authors.lastname: Oprea-Ilies
authors.affiliation: Department of Obstetrics and Gynecology, Morehouse School of Medicine, Atlanta, GA, United States.
authors.forename: Roland
authors.initials: R
authors.lastname: Matthews
keywords: Chemotherapy; Human chorionic gonadotropin